Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

People

MS Research Roundup: 27 February 2016

Research Roundup logo
FDA Fast-Tracks PPMS Drug Review; Molecular Target Runs Out of Air; Happy Accidents in the Lab; New Twist on Patient-Powered Research
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research, Meetings, People

PodBlog: B-Cell Double Header

Podcast logo
In episodes 56 and 57 of the MS Discovery podcast, Gavin Giovannoni, MBBCH, PhD, and Timothy Vollmer, MD, discuss the first large-scale study of a drug showing some benefits in a progressive form of multiple sclerosis. The story goes back decades, as Stephen Hauser, MD, recently explained.
A former beauty queen made a big impression on Stephen Hauser, MD, when he was...
Clinical Research, Drug Development, Laboratory Research, Meetings, People

PodBlog: Status of Stem Cell Therapies for MS

MSDF Podcast logo
Episode 55 of the MSDF podcast features Michael Levy, MD, PhD, of Johns Hopkins University School of Medicine, who discusses the status of regenerative stem cell therapies for multiple sclerosis.
Episode 55 of the MSDF podcast is out. Check it out. The podcast features an interview with...
Clinical Research, Drug Development, Laboratory Research, Meetings, People

Time to Rethink CIS Criteria

Jagan Avasarala
It’s time to rethink the diagnostic criteria for clinically isolated syndrome. CIS is defined as...
About 20% of patients do not meet the diagnostic criteria of clinically isolated syndrome (CIS) based on radiological and clinical evidence. Patients who do not fit the CIS diagnostic criteria may yet have oligoclonal bands distinct to CSF, increased IgG synthesis rate and IgG index and must be treated as if they carried a diagnosis of CIS.
Methods, People

Pages

Subscribe to RSS - People